Pericardial vascular patches are medical implants used in cardiovascular surgery to repair or reconstruct damaged blood vessels, particularly in the heart and surrounding structures. These patches are made from pericardial tissue, which is the membrane that surrounds the heart. Pericardial tissue is often preferred for vascular patching due to its biocompatibility, durability, and similarity to native blood vessels.

The global Pericardial Vascular Patches market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Pericardial Vascular Patches Industry Forecast” looks at past sales and reviews total world Pericardial Vascular Patches sales in 2023, providing a comprehensive analysis by region and market sector of projected Pericardial Vascular Patches sales for 2024 through 2030.

This Insight Report provides a comprehensive analysis of the global Pericardial Vascular Patches landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest development
• M&A activity

This report also analyzes the strategies of leading global companies with a focus on Pericardial Vascular Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pericardial Vascular Patches.

1. United States market for Pericardial Vascular Patches is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
2. China market for Pericardial Vascular Patches is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
3. Europe market for Pericardial Vascular Patches is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Pericardial Vascular Patches players cover:

• Abbott
• Edwards Lifesciences
• FOC Medical
• Tisgenx
• Collagen Solutions

This report presents a comprehensive overview, market shares, and growth opportunities of the Pericardial Vascular Patches market by:

• Product type
• Application
• Key manufacturers
• Key regions and countries

Segmentation by Type:

• Porcine Patch
• Bovine Patch
• Equine Patch
• Others

Segmentation by Application:

• Hospitals
• Ambulatory Care Centers
• Diagnostic Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, and market penetration:

• Abbott
• Edwards Lifesciences
• FOC Medical
• Tisgenx
• Collagen Solutions
• Artivion
• Baxter
• LeMaitre
• W. L. Gore & Associates
• Labcor
• RTI Surgical (RTI)

Key Questions Addressed in this Report:

• What is the 10-year outlook for the global Pericardial Vascular Patches market?
• What factors are driving Pericardial Vascular Patches market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Pericardial Vascular Patches market opportunities vary by end market size?
• How does Pericardial Vascular Patches break out by Type, by Application?